Prevalence of Strongyloides stercoralis infection among African children: A systematic review and meta-analysis
- Journal
- PLoS neglected tropical diseases (Q1)
- Published
- 7 October 2026
- Study design
- Systematic review of cohort studies
- Evidence level
- Level 2, Moderate (CEBM 2a)
- Authors
- Tadesse Hailu, Arancha Amor, Getaneh Alemu, Hiwot Tadesse, Veeranoot Nissapatorn, Hesham Al-Mekhlafi
- PMID
- 42842615
- DOI
- 10.1371/journal.pntd.0014759
Why clinicians should know about it
- Picked for Epidemiology (top studies of the week, 11 October 2026): Systematic review of Strongyloides prevalence in African children
Abstract
Strongyloides stercoralis is a neglected parasite that causes strongyloidiasis. However, the true prevalence of strongyloidiasis is underreported due to low-sensitivity diagnostic methods. This systematic review assessed the prevalence of S. stercoralis among African children and its variation by diagnostic methods, countries, and study settings. All studies published in African countries on S. stercoralis prevalence up to the year 2025 in the PubMed, Google Scholar, Scopus, and ScienceDirect databases were included. Identification, screening, checking the eligibility, and including the relevant studies were done following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Out of 651 articles screened, 27 studies involving 16,358 children were included in the systematic review. The pooled prevalence of S. stercoralis among African children was 14% using a random-effect model. The highest pooled prevalence of S. stercoralis was recorded at 27% in Côte d'Ivoire, followed by 26% in Ethiopia. A high prevalence (36%) of S. stercoralis was obtained by a combination of PCR, culture, and microscopic diagnostic methods. This review indicated that S. stercoralis prevalence in African children is considerable and likely underestimated due to low-sensitivity diagnostics. Therefore, further studies using sensitive diagnostic approaches are urgently needed to determine the true burden of strongyloidiasis.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.